Thomas Wilder

CIK 1491299 · last filed 2026-02-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.62M

Companies

2

Total Filings

54

Lifetime Open-Market Net

-$1.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
PEN	Director	5,095	$318.71	$1.62M	-$979.7K	35	2026-02-18
ENDOLOGIX INC /DE/ (ELGX) Delisted	Director	27,864	—	—	-$854.7K	18	2019-10-01

Recent Filings · Page 4 of 6

54 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-02-12	PEN	Grant (A)	+949	$0	EDGAR
2019-01-04	PEN	Sell (S)	−152	-$18.3K	EDGAR
2019-01-02	ENDOLOGIX INC /DE/ (ELGX) Delisted	Grant (A)	+120,887	$0	EDGAR
2018-10-04	PEN	Sell (S)	−151	-$22.2K	EDGAR
2018-07-13	PEN	Sell (S)	−304	-$42.1K	EDGAR
2018-02-21	PEN	Grant (A)	+1,215	$0	EDGAR
2018-01-04	PEN	Sell (S)	−345	-$31.4K	EDGAR
2017-10-04	PEN	Sell (S)	−345	-$31.1K	EDGAR
2017-07-20	PEN	Sell (S)	−345	-$29.7K	EDGAR
2017-06-02	ENDOLOGIX INC /DE/ (ELGX) Delisted	Grant (A)	+22,822	$0	EDGAR

Showing 31–40 of 54

Prev Page 4 of 6 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.